Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice: Erratum

The authors regret that the original version of our paper contains an error in partially overlapping the images of the "sham" and "oil" groups in Figure 1D. This may be due to incorrect image selection during the initial draft writing and failure to carefully check the images before final version confirmation.

The correct Figure 1 appears below.

Figure 1.

Expression of Piezo1 in macrophage has increased in fibrotic livers. (A) Representative images of H&E, Masson's, immunochemistry staining of Piezo1 and dual immunofluorescence staining with CD68 (green) and Piezo1 (red) in human liver samples. Scale bar, H&E and Masson's, 400 μm; immunochemistry, 200 μm; immunofluorescence, 50 μm, enlarge, 5.75 μm. (B) Representative images of Piezo1 staining and quantification of positive area in liver sections of C57BL/6J mice. Scale bar, 50 μm. (C) Relative mRNA expression of Piezo1 in liver tissues of C57BL/6J mice. (D) Representative images of dual immunofluorescence staining with CD68 (red) and Piezo1 (green) in liver sections of C57BL/6J mice. Scale bar, 25 μm; enlarge, 5 μm. (E) Relative mRNA expression of Piezo1 in BMDMs isolated from C57BL/6J mice. Data are presented as mean ± S. E. M.; Human samples: control (n = 3), HBV-related HCC (n = 4), PBC (n = 5), BA (n = 4), cholangiectasis (n = 4); mice samples (n = 6 for each group); cell samples (n = 4 for each group). *P < 0.05.